Biotech China 2014
RNAi for Therapeutic Indications
Fairmont Hotel
170 South Market Street
San Jose, CA
http://www.healthtech.com/gta/rns/rnx?c=6771
 RNAi for Therapeutic Indications
Cambridge Healthtech Institute
Fairmont Hotel

Schedule of Presentations:

Tuesday, June 9, 2009
07:00:00 check-In
12:00:00 EXECUTIVE FORUM [Shared Session] Bob D. Brown
12:00:00 Registration for RNAi for Therapeutic Indications and RNAi for Target Identification and Validation Conferences
13:00:00 I. Surveying RNAi Opportunities: From Tools to Therapies Thomas Singer, Elena Feinstein, Arthur M Krieg, Klaus Giese
15:35:00 Sponsored Presentation (Opportunity Available)
15:50:00 Networking Refreshment Break Poster and Exhibit Viewing
16:00:00 II. Navigating the Intellectual Property Landscape Steven L. Highlander, Rochelle K. Seide, Kathleen M. Williams
17:45:00 End of Day
18:00:00 Announcements
18:00:00 Discussion
Wednesday, June 10, 2009
07:00:00 Facilitated Break-Out Discussion Groups and Continental Breakfast
07:00:00 Registration Open
07:20:00 MAKING RNAi THERAPIES A REALITY
08:15:00 Chairperson’s Remarks Cristina M. Rondinone
08:20:00 Development of an RNAi Therapeutic for Colon Polyposis Johannes Fruehauf
08:50:00 Development of SNALP Formulated siRNA-Based Drugs Ian MacLachlan
09:20:00 Atu027, a Liposomal siRNA Formulation Targeting PKN3, Inhibits Cancer Progression Klaus Giese
09:50:00 Networking Coffee Break Poster and Exhibit Viewing
10:45:00 Delivery of shRNA and Other Anti-HIV RNAs by Autologous Transplantation of Lentivirus-Transduced CD34+ Cells: A Feasibility Trial John Zaia
11:15:00 Bringing up CALAA-01: The First Nanoparticle-Formulated siRNA for Cancer in the Clinic Helen F. Chuang
11:45:00 Non-Invasive siRNA Therapeutics for Treatment of Eye, Inner Ear, and Lung Pathologies Elena Feinstein
12:15:00 SPONSORED LUNCHEON PRESENTATIONS
12:15:00 Conception of Circular Interfering RNA and Production’s Strategy Guillaume Plane
12:30:00 Presentation 1 (Opportunity Available) or Lunch on Your Own
13:00:00 Session Break
13:05:00 or Therapeutic Indications Presentation Topic
13:45:00 Chairperson’s Remarks Arthur M. Krieg
13:50:00 Understanding the Immune Effects of RNA Arthur M. Krieg
14:20:00 Non-Clinical Safety Assessment of siRNA-Based Therapeutics Thomas Singer
14:50:00 Networking Refreshment Break (Last Chance for Poster and Exhibit Viewing)
15:30:00 Optimization of shRNA Features for Targeting Hepatitis C Virus Qing Ge
16:00:00 siRNA-Based Topical Microbicides Targeting Sexually Transmitted Diseases Deborah Palliser
16:30:00 Developing Multi-Targeted siRNA Therapeutics for Treatment of Critical Human Diseases Patrick Y. Lu
17:00:00 Adaptors: A Novel Gene Silencing Technology Mark Behlke
17:30:00 Close of RNAi for Therapeutic Indication Conference Related Resources & Products PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009 (Hardcopy) ADAPT 2009: Accelerating Development & Advancing Personalized Therapy RNAi for Functional Screens RNAi for Functional Screens Tackling RNAi Delivery Tackling RNAi Delivery The Business of Genomics The Business of Genomics
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.